Hypertension, Vol 3, 75-80, Copyright © 1981 by American Heart Association
D Trachewsky
This study investigated whether the riboflavin analogs, 7,8-dimethyl-10-
formylmethyl isoalloxazine (FMI) and 7,8-dimethyl-10-(2'-hydroxyethyl)
isoalloxazine (HEI), are effective antihypertensive agents in
mineralocorticoid-induced or deoxycorticosterone acetate (DOCA)-salt
hypertension. These studies are based on our previous observation tht
aldosterone enhances the biosynthesis of renal flavin mononucleotide (FMN)
and flavin adenine dinucleotide (FAD) from riboflavin, and that FMI and HEI
competitively inhibit conversion of riboflavin to FMN and reabsorption of
Na+ in the kidney of adrenalectomized rats. When 1.6 mg of FMI or HEI were
administered simultaneously with 3.0 mg of DOCA, the tail systolic blood
pressure (SBP) of unanesthetized rats rose only to 136 +/- 5 mm Hg
(standard error of the mean, SEM) compared to 163 +/- 5 mm Hg during DOCA
therapy alone (p less than 0.0005). This hypotensive effect of FMI or HEI
was noted after the fourth week of treatment and persisted through the
ninth week. The rats tolerated the medication well and had no signs of
riboflavin deficiency. DOCA administration alone resulted in a 24% increase
in iliopsoas muscle Na+ concentration (p less than 0.0005), and a 0.8%
increase in the water content of the muscle (p less than 0.025), suggesting
a positive Na+ balance. Administration of FMI or HEI blunted the ability of
DOCA to increase muscle Na+ concentration (p less than 0.025), water
content (p less than 0.01). HEI treatment of the Kyoto strain of
spontaneously hypertensive rats (SHR) did not lower their mean SBP. Thus it
appears that the hypotensive actions of FMI or HEI are closely associated
with their ability to modify the effects of mineralocorticoids on NA+
balance.
ARTICLES
Antihypertensive effect of riboflavin analogs in rats with mineralocorticoid-induced hypertension
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1981 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |